Patient adherence to drug therapy for bipolar disorder

Patient adherence to drug therapy for bipolar disorder

 

Authors

 

S.N. Vasilieva

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

G.G. Simutkin

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

E.D. Schastnyy

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

E.V. Lebedeva

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

A.K. Surovtseva

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

N.S. Smirnova

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

E.V. Didenko

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation

 

https://doi.org/10.26617/1810-3111-2024-2(123)-41-48

 

Journal: Siberian Herald of Psychiatry and Addiction Psychiatry. 2024; 2 (123):  41-48.

 

Abstract

Background. Depressive symptoms are often associated with low adherence to therapy, which prompts the interest of researchers in developing high-tech ways to increase compliance. The problem of patient refusal of therapy for bipolar disorder remains relevant, since non-compliance with doctor’s recommendations by patients still reaches a high level and gives rise to many negative medical and socio-economic consequences, despite the emergence of safe and easy-to-use forms of medications for treatment of this disorder. Objective: to evaluate adherence to prescribed psychopharmacotherapy in psychiatric patients with bipolar disorder with subsequent development of psychoeducational programs to increase adherence to psychopharmacotherapy. Material and Methods. Inpatients (n=61) with bipolar disorder (44 women and 17 men) were treated at the Affective States Department of Mental Health Research Institute of Tomsk National Research Medical Center. The mean age of women was higher (47.0 [25.0; 57.0] years) than that of men (32.0 [11.9; 36.0] years). Research methods used were as follows: clinical-psychopathological, clinical-follow-up, psychometric, statistical. Results. The low level of adherence to psychopharmacotherapy was revealed in inpatients with bipolar disorder. Conclusion. Patients with bipolar disorder required a personalized choice of psychopharmacotherapy and psychoeducational techniques that increased their adherence to prescribed drug therapy.

 

Keywords: bipolar affective disorder, timely recognition, optimal psychopharmacotherapy, adherence to treatment.

 

Article (pdf)

 

Contacts

 

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Materials  

For citation: Vasilieva S.N., Simutkin G.G., Schastnyy E.D., Lebedeva E.V., Surovtseva A.K., Smirnova N.S., Didenko E.V. Patient adherence to drug therapy for bipolar disorder. Siberian Herald of Psychiatry and Addiction Psychiatry.2024; 2 (123): 41-48. https://doi.org/10.26617/1810-3111-2024-2(123)-41-48

 

REFERENCES

  1. Tyuvina NA, Stolyarova AE, Balabanova VV, Bunkova KM, Efremova EN. A comparative study of treatment for depression in women and men suffering from bipolar affective disorder. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):59-66. DOI: 10.14412/2074-2711-2021-3-59-66(inRussian).
  2. Greene M, Yan T, Chang E, Hartry A, Touya M, Broder MS. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder. J Med Econ. 2018 Feb;21(2):127-134. doi: 10.1080/13696998.2017.1379412. Epub 2017 Sep 29. PMID: 28895758.
  3. Barbuti M, Colombini P, Ricciardulli S, Amadori S, Gemmellaro T, De Dominicis F, Della Rocca F, Petrucci A, Schiavi E, Perugi G. Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in a sample of bipolar patients: a prospective naturalistic study. Int Clin Psychopharmacol. 2021 Sep 1;36(5):230-237. doi: 10.1097/YIC.0000000000000373. PMID: 34310434.
  4. Lazary J, Pogany L, De Las Cuevas C, Villasante-Tezanos GA, De Leon J. Adherence to psychiatric medications: Comparing patients with schizophrenia, bipolar disorder and major depression. Neuropsychopharmacol Hung. 2021 Dec 1;23(4):363-373. PMID: 34971494.
  5. Scott J, Colom F, Pope M, Reinares M, Vieta E. The prognostic role of perceived criticism, medication adherence and family knowledge in bipolar disorders. J Affect Disord. 2012 Dec 15;142(1-3):72-6. doi: 10.1016/j.jad.2012.04.005. Epub 2012 Sep 1. PMID: 22944191.
  6. Youn H, Lee MS, Jeong HG, Kim SH. Evaluation of factors associated with medication adherence in patients with bipolar disorder using a medication event monitoring system: a 6-month follow-up prospective study. Ann Gen Psychiatry. 2022 Aug 23;21(1):33. doi: 10.1186/s12991-022-00411-4. PMID: 35999628; PMCID: PMC9400298.
  7. Li NC, Alcusky M, Masters GA, Ash AS. Association of social determinants of health with adherence to second-generation antipsychotics for people with bipolar disorders in a medicaid population. Med Care. 2022 Feb 1;60(2):106-112. doi: 10.1097/MLR.0000000000001670. PMID: 34908010.
  8. Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP; Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70 Suppl 4:1-46; quiz 47-8. PMID: 19686636.
  9. Alcalá JÁ, Fontalba-Navas A, Company-Morales M, Romero-Guillena SL, Gutiérrez-Higueras T, Gutiérrez-Rojas L. Facilitators and barriers of medication adherence based on beliefs of persons with bipolar disorder: a qualitative study. int j environ res public health. 2022 Jun 22;19(13):7633. doi: 10.3390/ijerph19137633. PMID: 35805291; PMCID: PMC9265403.
  10. Ghosh P, Balasundaram S, Sankaran A, Chandrasekaran V, Sarkar S, Choudhury S. Factors associated with medication non-adherence among patients with severe mental disorder ‒ A cross sectional study in a tertiary care Centre. Explor Res Clin Soc Pharm. 2022 Sep 12;7:100178. doi: 10.1016/j.rcsop.2022.100178. PMID: 36161207; PMCID: PMC9493377.
  11. Perich T, Mitchell PB, Vilus B. Stigma in bipolar disorder: A current review of the literature. Aust N Z J Psychiatry. 2022 Sep;56(9):1060-1064. doi: 10.1177/00048674221080708. Epub 2022 Feb 16. PMID: 35172630.
  12. Ghosal S, Mallik N, Acharya R, Dasgupta G, Mondal DK, Pal A. Medication adherence in bipolar disorder: Exploring the role of predominant polarity. Int J Psychiatry Med. 2021 Jul 1:912174211030163. doi: 10.1177/00912174211030163. PMID: 34196229.
  13. Bessonova L, Ogden K, Doane MJ, O'Sullivan AK, Tohen M. The economic burden of bipolar disorder in the United States: a systematic literature review. Clinicoecon Outcomes Res. 2020 Sep 7;12:481-497. doi: 10.2147/CEOR.S259338. PMID: 32982338; PMCID: PMC7489939.
  14. Kraiss JT, Wijnen B, Kupka RW, Bohlmeijer ET, Lokkerbol J. Economic evaluations of non-pharmacological interventions and cost-of-illness studies in bipolar disorder: A systematic review. J Affect Disord. 2020 Nov 1;276:388-401. doi: 10.1016/j.jad.2020.06.064. Epub 2020 Jul 15. PMID: 32871669.
  15. Doane MJ, Ogden K, Bessonova L, O'Sullivan AK, Tohen M. Real-world patterns of utilization and costs associated with second-generation oral antipsychotic medication for the treatment of bipolar disorder: a literature review. Neuropsychiatr Dis Treat. 2021 Feb 16;17:515-531. doi: 10.2147/NDT.S280051. PMID: 33623386; PMCID: PMC7896797.
  16. Mavranezouli I, Lokkerbol J. A systematic review and critical appraisal of economic evaluations of pharmacological interventions for people with bipolar disorder. Pharmacoeconomics. 2017 Mar;35(3):271-296. doi: 10.1007/s40273-016-0473-1. PMID: 28000158.
  17. Chakrabarti S. Treatment-adherence in bipolar disorder: A patient-centred approach. World J Psychiatry. 2016 Dec 22;6(4):399-409. doi: 10.5498/wjp.v6.i4.399. PMID: 28078204; PMCID: PMC5183992.
  18. Narayanan D, Jith A, Bansal R. Nonadherence in bipolar disorder patients: A 14-year retrospective study. Indian J Psychiatry. 2020 May-Jun;62(3):290-294. doi: 10.4103/psychiatry.IndianJPsychiatry_ 357_19. Epub 2020 May 15. PMID: 32773872; PMCID: PMC7368454.
  19. Azadforouz S, Shabani A, Nohesara S, Ahmadzad-Asl M. Non-compliance and related factors in patients with bipolar i disorder: a six-month follow-up study. Iran J Psychiatry Behav Sci. 2016 Mar 15;10(2):e2448. doi: 10.17795/ijpbs-2448. PMID: 27803718; PMCID: PMC5087110.
  20. Başkaya E, Demir S. Effect of treatment adherence training given to patients with bipolar disorder on treatment adherence, social functioning and quality of life: A pilot study. Complement Ther Clin Pract. 2022 Feb;46:101504. doi: 10.1016/j.ctcp.2021.101504. Epub 2021 Oct 29. PMID: 34731769.
  21. Youn H, Lee MS, Jeong HG, Kim SH. Evaluation of factors associated with medication adherence in patients with bipolar disorder using a medication event monitoring system: a 6-month follow-up prospective study. Ann Gen Psychiatry. 2022 Aug 23;21(1):33. doi: 10.1186/s12991-022-00411-4. PMID: 35999628; PMCID: PMC9400298.
  22. Mengistu ME, Berassa SH, Kassaw AT, Dagnew EM, Mekonen GA, Birarra MK. Assessments of functional outcomes and its determinants among bipolar disorder patients in Northwest Ethiopia comprehensive specialized hospitals: a multicenter hospital-based study. Ann Gen Psychiatry. 2023 Apr 6;22(1):14. doi: 10.1186/s12991-023-00444-3. PMID: 37024899; PMCID: PMC10077702
  23. Bipolar disorder. Clinical guidelines. Moscow, 2023:145. Developer: Russian Society of Psychiatrists. Approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation https://cr.minzdrav.gov.ru/schema/675_1(in Russian).
  24. Mosolov SN, Kostyukova EG, Kuzavkova MV. Bipolar disorder: diagnostics and therapy. S.N. Mosolov, ed. Moscow: MEDpressinform Publishing House, 2008. 384 (in Russian).
  25. Bokhan NA, Semke VYa. Co-morbidity in Addiction Psychiatry. Tomsk: Publishing House of Tomsk University, 2009:498(in Russian).
  26. Nabavi B, Mitchell AJ, Nutt D. A Lifetime prevalence of comorbidity between bipolar affective disorder and anxiety disorders: a meta-analysis of 52 interview-based studies of psychiatric population. EBioMedicine. 2015 Sep 8;2(10):1405-19. doi: 10.1016/j.ebiom.2015.09.006. PMID: 26629535; PMCID: PMC4634892.
  27. Hsu HE, Chen PY, Chang HM, Pan CH, Su SS, Tsai SY, Chen CC, Kuo CJ. Incidence of and risk factors for alcohol dependence in bipolar disorder: A population-based cohort and nested case-control study. Aust N Z J Psychiatry. 2023 May;57(5):725-735. doi: 10.1177/00048674221100153. Epub 2022 Jun 1. PMID: 35642594.
  28. Vasilieva SN, Simutkin GG, Schastnyy ED, Lebedeva EV, Bokhan NA. Bipolar disorder: comorbidity with other mental disorders. Psychiatry (Moscow). 2021;19(3):15-21. https://doi.org/10.30629/2618-6667-2021-19-3-15-21(in Russian).
  29. Vasilieva SN, Simutkin GG, Schastnyy ED, Surovtseva AK, Ukraintsev II, Altynbekov KS. Combination of mood disorders and alcohol dependence: clinical significance of comorbidity, social adaptation of patients. Siberian Herald of Psychiatry and Addiction Psychiatry. 2022; 4 (117): 14-21. https://doi.org/10.26617/1810-3111-2022-4(117)-14-21(in Russian).
  30. Simutkin GG, Bokhan NA, Ivanova SA. Probabilistic diagnosis of bipopolar affective disorder: modern approaches, possibly and restrictions. Tomsk: Printing House Integrated Casework, 2023:162 (in Russian).
  31. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334:1-100. doi: 10.1111/j.1600-0447.1987.tb10566.x. PMID: 2887090.